Notably, the impact of SH2B3 LoF appears to be age-dependent with features of MPD in newborns and young infants and isolated thrombocytosis later in childhood, suggesting that SH2B3 variants have different effects on fetal and adult hematopoiesis. Here, SH2B3 is linked to myeloproliferative neoplasm.